Randomized study exploring the combination of radiotherapy with two types of acupuncture treatment (ROSETTA): study protocol for a randomized controlled trial by Asadpour, Rebecca et al.
STUDY PROTOCOL Open Access
Randomized study exploring the
combination of radiotherapy with two
types of acupuncture treatment (ROSETTA):
study protocol for a randomized controlled
trial
Rebecca Asadpour1, Kerstin A. Kessel1,2, Tom Bruckner3, Serkan Sertel4,6,7 and Stephanie E. Combs1,2,5*
Abstract
Background: Adverse effects such as fatigue, pain, erythema, nausea and vomiting are commonly known in
patients undergoing irradiation (RT) alone or in combination with chemotherapy (RCHT). Patients suffering from
these symptoms are limited in their daily life and their quality of life (QOL) is often reduced. As addressed in several
trials, acupuncture can cause amelioration of these specific disorders. Especially for pain symptoms, several groups
have shown efficacy of acupuncture. To what extent the difference between traditional acupuncture (verum acupuncture)
and false acupuncture (sham acupuncture) is in reducing side effects and improvement of QOL is not clear.
Methods/design: ROSETTA is a prospective randomized phase II trial (version 1.0) to examine the efficacy of traditional
acupuncture in patients with RT-related side effects. In the experimental (verum) arm (n = 37) an experienced
acupuncture-trained person will treat dedicated acupuncture points. In the control (sham) arm (n = 37) sham acupuncture
will be performed to provide a blinded comparison of results.
Discussion: This is the first randomized prospective trial to evaluate the effect of traditional acupuncture on RT-related
side effects such as fatigue and QOL.
Trial registration: ClinicalTrials.gov, NCT02674646. Registered on 8 December 2015.
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Background
Radiation therapy (RT) is a main pillar in cancer care of-
fering curative treatment in several indications. However,
RT-related side effects develop depending on the site
treated (e.g. head and neck or prostate etc.), and on in-
dividual patients’ predisposition or other factors. One
of the main symptoms related to cancer treatment is
the development of fatigue, which can evolve during
RT and commonly persists some time after completion
of treatment. Other side effects, depending on the region
treated, include headache, nausea/vomiting, gastrointestinal
discomfort, dysuria and others. Fatigue and subsequently a
reduction in overall quality of life (QOL) is a main discom-
forting factor for patients treated with RT; in many patients
fatigue is the only side effect observed during RT.
Commonly, this leads to a reduction of daily activity
and motivation, and can result in severe unhappiness
and/or depression. Thus, methods for amelioration of
symptoms and especially any possibilities to reduce fatigue
and increase QOL are important factors for patients in the
oncology setting.
Several means of supportive care to ameliorate pa-
tients’ RT-related side effects are described. In general, it
has been shown that moderate exercise can improve
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QOL and reduce fatigue during and after treatment;
additionally, light to moderate exercise can lead to im-
provement in oncological outcome [1, 2]. Other comple-
mentary treatments including selenium, mistletoe or
several vitamins are controversial due to limited data on
significant benefit; depending on the substances’ mecha-
nisms of action, the risk of RT-related side effects may
be increased. Complementary medicine such as traditional
Chinese medicine (TCM) or other naturopathy concepts
are consistently in discussion and are offered by many
practitioners on a case-by-case basis.
For acupuncture, which is on pillar amongst others
within the TCM concept, there are some data from ran-
domized studies on back pain, headaches and other non-
cancer diseases [3–15]. A large German research consor-
tium, the GERAC-Group, has shown that acupuncture
can have a significantly beneficial effect on chronic
headache, back pain and joint and bone pain due to ar-
throsis [16–21]. In oncology, some centers have evalu-
ated the effect of acupuncture on RT-related side effects,
such as mucositis and dysphagia, and demonstrated sig-
nificant reduction of symptoms [3, 10, 22–24]. However,
most studies included only a small number of patients,
and have not evaluated effects on general fatigue, QOL
or other RT-related symptoms.
The prospective phase II ROSETTA trial (version 1.0)
will include patients with tumors treated with RT in
various anatomical regions. In the experimental arm an
experienced acupuncture-trained person will treat dedi-
cated traditional acupuncture points. In the control arm
control acupuncture will be performed to provide a
blinded comparison of results. Sham acupuncture was
developed especially for randomized controlled trials as
a valid comparator; compared to a pure control arm, pa-
tients receive acupuncture with needlepoints, that have
no medical function and thus do not have any proven ef-
fect on the symptoms addressed [23–29].
Methods
Endpoints of the study
In the ROSETTA trial the main endpoint is improvement
of QOL and reduction of fatigue. Secondary endpoints are
reduction of RT-related side effects such as headache,
nausea and skin erythema.
Study design
The ROSETTA trial will evaluate the effect of acupunc-
ture as a complementary treatment parallel to RT. Acu-
puncture is an established and accepted treatment
method, which is indicated especially for pain reduction.
The plan for study is to recruit 74 patients. The total
study duration is planned to be 24 months.
After inclusion into the study and baseline examin-
ation, the patient is randomized into the treatment arm.
Randomization is performed under the auspices of the
biometrician. The randomization process will be per-
formed with the professional web-based patient
randomization service, e.g. at www.randomizer.at. The
investigator or an authorized member of the study
team will perform data documentation and evaluation.
Depending on the treatment arm either verum or
sham acupuncture will be applied [23, 24, 26, 28, 30,
31]. Acupuncture will be performed after treatment bi-
weekly during the first week of RT, thereafter weekly until
the end of RT. Treatment time in both arms is identical
and lies between 20 and 30 minutes. Every patient will be
treated according to the treatment arm. Standardized acu-
puncture needles (sterile needles, e.g. 0.24 × 40 mm) will
be used for both treatment types. Verum acupuncture is
based on foraminology, the ancient Chinese knowledge of
acupuncture points [32]. Control acupuncture is per-
formed on unspecific points with no specific effect ac-
cording to foraminology.
Patients will receive standardized questionnaires
(European Organization for Research and Treatment of
Cancer (EORTC) QLQ C-30) before their first, after
their fourth and after their last acupuncture treatment.
Patients will be questioned by the investigator about
their feelings and symptoms and detailed information
about their illness. The answers will be documented ac-
cording to the standardized scoring system (Common
Toxicity Criteria for Adverse Events (CTCAE)). The
schedule of enrollment, interventions and assessments
in the ROSETTA trial is depicted in Fig. 1.
Group A: verum acupuncture
Needlepoints
Bilateral PC 6, S 36, L 8, L 9
Unilateral R 4, R 6
Group B: control acupuncture
Needlepoints




After informed consent and inclusion into the study
protocol, a baseline examination will be performed. This
examination is to be performed within 2 days before ini-
tiation of study treatment and includes:
– complete medical history including concomitant
treatments
– clinical examination according to the regulation of
TCM
– ascertainment of QOL
– questionnaire on fatigue
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– documentation of any symptoms and sequelae prior
to radiotherapy
Follow-up examinations during study treatment
After every acupuncture treatment, an examination will
be performed. This examination includes:
– clinical examination according to the regulation of
TCM
– ascertainment of QOL
– questionnaire on fatigue
– documentation of any symptoms and sequelae
Follow up
The final study visit will be 6 weeks after treatment to as-
sess the primary endpoints. After the first 6 weeks, patients
will be included into a regular follow-up schedule according
to their primary disease and follow-up requirements.
General criteria for patient selection
All patients treated with RT or radiochemotherapy
(RCHT) can be included in the trial if fulfilling the inclu-
sion and exclusion criteria.
Inclusion criteria
Patients meeting all of the following criteria will be con-
sidered for the trial:
– treatment with radiotherapy
– age ≥ 18 years
– ability of subject to understand the nature and
individual consequences of the clinical trial
– written informed consent (must be available before
enrolment in the trial)
Exclusion criteria
Patients presenting with any of the following criteria will
not be included in the trial:
– any contraindication to acupuncture
– known coagulopathy or anticoagulation therapy
with bleeding time > 4 minutes, thrombocyte count
< 50 000/μl
– missing compliance
– skin disease in the region of the acupuncture points
– refusal of the patient to take part in the study
– participation in another clinical study or observation
period of competing trials
Statistical considerations
The study is powered to show that continuous acu-
puncture during RT can have a positive effect on QOL.
ROSETTA is a prospective randomized trial comparing
traditional (verum) acupuncture to control (sham) acu-
puncture. Randomization will be performed using
Fig. 1 Schedule of enrolment, interventions and assessments in the ROSETTA trial. EORTC European Organization for Research and Treatment of
Cancer, QOL quality of life, TCM Traditional Chinese Medicine
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automated information technology (IT)-based
randomization, and patients will be allocated to groups
by the Study Center within the Department of Radi-
ation Oncology, Technische Universität München
(TUM). Additionally, the study will evaluate whether
acupuncture can reduce QOL-related side effects such
as fatigue, headache, nausea etc.
All patient data on symptoms, side effects and QOL
according to the QOL questionnaires will be docu-
mented in our dedicated study database. Evaluation of
the primary endpoint (QOL) will be performed using the
Wilcoxon test (U test) and the evaluation tool provided
by the EORTC. The secondary endpoints (fatigue, head-
ache, nausea etc.) will be evaluated using comparable
statistical calculations. The interpretation of the data will
be purely descriptive.
The sample size calculation is based on the Wilcoxon
test and the primary endpoint. A sample size of 37 pa-
tients per group (i.e. 74 patients in total) is associated
with power of 80% to detect a difference between the
two groups (with two-sided α = 5%) using the Wilcoxon
test, with a probability of 69% that an increase in QOL
can be achieved when comparing the two groups 8 (d.h.
P(x < y).
Data management
In the ROSETTA trial the EORTC QLQ-C30 will be
used to document the QOL of patients during treat-
ment. Data on side effects and symptoms during RT will
be documented on dedicated case report forms (CRFs)
designed for the trial and documented in the institutional
database. All interventions and every other medical treat-
ment will be recorded. The data will be collected in ac-
cordance with all Data Protection Regulations in the
MiRO Database of the Department of Radiation On-
cology, TUM.
Discussion
Several studies have shown that traditional acupuncture
can alleviate clinical symptoms: In Germany, especially
for back pain, a multicenter study group has shown solid
data in this regard and provided a strong basis for the
use of acupuncture in this regard [16–21].
In oncology, a main focus of acupuncture treatment
centers is to reduce RT-related side effects of either
chemotherapy or RT. Meng et al. showed that acupunc-
ture can prevent RT-related xerostomia in patients with
nasopharyngeal cancer [7, 8]; Lu et al. focused on dys-
phagia in patients treated with RCHT for tumors of the
head and neck, and observed a substantial effect of acu-
puncture [33]. A comprehensive review on acupuncture
in cancer treatment illustrated that there have been 41
randomized controlled trials involving eight different
symptoms, such as pain, nausea, hot flashes, fatigue,
xerostomia, prolonged postoperative ileus, anxiety/mood
disorders and sleep disturbance [34]. Cochrane criteria
were used to classify the studies for risk of bias. Only a
few studies were identified to be free of risk of bias, or
to have a low risk of bias. Thus, more trials focusing on
clear questions and applying valid control arms are
needed to further clarify the role of acupuncture in on-
cology care.
To address these questions, the ROSETTA trial was
set up as a prospective randomized controlled trial. In the
control arm, sham-acupuncture points not associated with
any function in the doctrine of TCM are applied (sham
acupuncture). This concept has been applied in different
trials, in patients with and without cancer [3, 7, 8, 23, 24,
33, 35, 36]. Compared to a pure non-treatment controlled
trial, the bias of no treatment is not included in this trial
concept. In the experimental arm, valid acupuncture
points are used, which are known to reduce the associated
side effects (verum acupuncture). Therefore, the RO-
SETTA trial will help to clarify the assumed benefit of acu-
puncture in terms of fatigue and QOL in the oncology
setting in patients treated with RTAdditional file 1.
Status of the trial
Recruitment into the ROSETTA trial is ongoing at the
time of submission.
Additional file
Additional file 1: SPIRIT 2013 Checklist: Recommended items to address
in a clinical trial protocol and related documents. (DOC 110 kb)
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